Physician profile
Craig Elder
NPI 1073961637
$2,937.36
in general payments reported to CMS, 2019-2025
15 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 76% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2022: $210 · 2023: $582 · 2024: $741 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,617.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $471.02 | 2024-2025 | |
| Kerecis Limited | $440.22 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Cook Medical LLC | $299.46 | 2023 | Zilver Ptx |
| Stryker Corporation | $244.83 | 2025 | Variax, Na |
| Medtronic, INC. | $210.16 | 2022 | |
| Integra Lifesciences Corporation | $196.09 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Motiva USA, LLC | $176.06 | 2025 | |
| Acera Surgical, INC. | $152.96 | 2024 | Restrata Wound Matrix |
| Innovation Technologies INC | $149.02 | 2025 | Irrisept |
| W. L. Gore & Associates, INC. | $137.89 | 2023 | Gore Synecor Biomaterial |
| Polynovo North America LLC | $129.00 | 2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $115.61 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $109.54 | 2019 | |
| Intuitive Surgical, INC. | $84.24 | 2023 | Da Vinci Surgical System |
| Davol INC. | $21.26 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.